D. van der Waaij
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria 29
- Endocrinology top 2%
- Infectious Diseases top 2%
- Clostridium difficile and Clostridium perfringens research 18
-
- Neutropenia and Cancer Infections 23
-
- Gut microbiota and health 22
-
- Probiotics and Fermented Foods 17
-
- Antibiotics Pharmacokinetics and Efficacy 16
-
- Mycobacterium research and diagnosis 12
-
- Oral health in cancer treatment 9
- Co-authors
- H. G. de Vries-HospersPeter J. HeidtD. W. van BekkumJan L.N. RoodenburgLauren A. van der WaaijP. C. LimburgG MesanderNanno H. Mulder
- Journals
- Infection (18 papers)Epidemiology and Infection (13 papers)Antonie van Leeuwenhoek (4 papers)
- Partner nations
- NetherlandsNorth MacedoniaGermany
In The Last Decade
D. van der Waaij
111 papers receiving 3.0k citations
Hit Papers
Peers
Comparison fields: 5 of 122
- Molecular Medicine 522
- Critical Care and Intensive Care Medicine 317
- Endocrinology 300
- Infectious Diseases 936
- Applied Microbiology and Biotechnology 76
Countries citing papers authored by D. van der Waaij
This map shows the geographic impact of D. van der Waaij's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. van der Waaij with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. van der Waaij more than expected).
Fields of papers citing papers by D. van der Waaij
This network shows the impact of papers produced by D. van der Waaij. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. van der Waaij. The network helps show where D. van der Waaij may publish in the future.
Co-authorship network
The 25 scholars most cited alongside D. van der Waaij, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 166 | |
| 2 | 1994 | 16 | |
| 3 | 1993 | 8 | |
| 4 | 1993 | 10 | |
| 5 | 1993 | 6 | |
| 6 | 1992 | 7 | |
| 7 | 1992 | 13 | |
| 8 | 1992 | 22 | |
| 9 | 1991 | 25 | |
| 10 | 1991 | 4 | |
| 11 | 1990 | 6 | |
| 12 | 1989 | 7 | |
| 13 | 1988 | 2 | |
| 14 | 1988 | 7 | |
| 15 | 1987 | 40 | |
| 16 | 1987 | 9 | |
| 17 | 1986 | 14 | |
| 18 | Antibiotic choice : the importance of colonisation resistance | 1983 | 10 |
| 19 | 1977 | 63 | |
| 20 | Formation, Growth and Multiplication of Toxoplasma gondii Cysts in Mouse Brains. | 1959 | 17 |
About D. van der Waaij
D. van der Waaij is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology and Endocrinology, having authored 113 papers that have together received 3.5k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (29 papers), Neutropenia and Cancer Infections (23 papers), Gut microbiota and health (22 papers), Clostridium difficile and Clostridium perfringens research (18 papers), Probiotics and Fermented Foods (17 papers), Antibiotics Pharmacokinetics and Efficacy (16 papers), Mycobacterium research and diagnosis (12 papers) and Oral health in cancer treatment (9 papers). The work is most often cited by research in Molecular Medicine (522 citations), Critical Care and Intensive Care Medicine (317 citations) and Endocrinology (300 citations). D. van der Waaij has collaborated with scholars based in Netherlands, North Macedonia and Germany. Frequent co-authors include H. G. de Vries-Hospers, Peter J. Heidt, D. W. van Bekkum, Jan L.N. Roodenburg, Lauren A. van der Waaij, P. C. Limburg, G Mesander, Nanno H. Mulder, Dirk Th. Sleijfer and Carl Erik Nord. Their work appears in journals such as Infection, Epidemiology and Infection, Antonie van Leeuwenhoek, The Journal of Infectious Diseases and Journal of Antimicrobial Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.